474 related articles for article (PubMed ID: 21471086)
1. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.
Laughon MM; Langer JC; Bose CL; Smith PB; Ambalavanan N; Kennedy KA; Stoll BJ; Buchter S; Laptook AR; Ehrenkranz RA; Cotten CM; Wilson-Costello DE; Shankaran S; Van Meurs KP; Davis AS; Gantz MG; Finer NN; Yoder BA; Faix RG; Carlo WA; Schibler KR; Newman NS; Rich W; Das A; Higgins RD; Walsh MC;
Am J Respir Crit Care Med; 2011 Jun; 183(12):1715-22. PubMed ID: 21471086
[TBL] [Abstract][Full Text] [Related]
2. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.
Jensen EA; Dysart K; Gantz MG; McDonald S; Bamat NA; Keszler M; Kirpalani H; Laughon MM; Poindexter BB; Duncan AF; Yoder BA; Eichenwald EC; DeMauro SB
Am J Respir Crit Care Med; 2019 Sep; 200(6):751-759. PubMed ID: 30995069
[No Abstract] [Full Text] [Related]
3. Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study.
Keller RL; Feng R; DeMauro SB; Ferkol T; Hardie W; Rogers EE; Stevens TP; Voynow JA; Bellamy SL; Shaw PA; Moore PE;
J Pediatr; 2017 Aug; 187():89-97.e3. PubMed ID: 28528221
[TBL] [Abstract][Full Text] [Related]
4. Survival without Bronchopulmonary Dysplasia of Extremely Preterm Infants: A Predictive Model at Birth.
Baud O; Laughon M; Lehert P
Neonatology; 2021; 118(4):385-393. PubMed ID: 34004607
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of an Online Risk Estimator for Bronchopulmonary Dysplasia in Predicting Corticosteroid Treatment in Infants Born Preterm.
Cuna A; Liu C; Govindarajan S; Queen M; Dai H; Truog WE
J Pediatr; 2018 Jun; 197():23-28.e2. PubMed ID: 29551313
[TBL] [Abstract][Full Text] [Related]
6. The Prediction of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants through Clinical Indicators within 1 Hour of Delivery.
Shim SY; Yun JY; Cho SJ; Kim MH; Park EA
J Korean Med Sci; 2021 Mar; 36(11):e81. PubMed ID: 33754511
[TBL] [Abstract][Full Text] [Related]
7. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S; Bay J; Franz AR; Ehrhardt H; Klein L; Petzinger J; Binder C; Kirschenhofer S; Stein A; Hüning B; Heep A; Cloppenburg E; Muyimbwa J; Ott T; Sandkötter J; Teig N; Wiegand S; Schroth M; Kick A; Wurm D; Gebauer C; Linnemann K; Kittel J; Wieg C; Kiechl-Kohlendorfer U; Schmidt S; Böttger R; Thomas W; Brevis Nunez F; Stockmann A; Kriebel T; Müller A; Klotz D; Morhart P; Nohr D; Biesalski HK; Giannopoulou EZ; Hilt S; Poryo M; Wagenpfeil S; Haiden N; Ruckes C; Ehrlich A; Gortner L;
Lancet Respir Med; 2024 Jul; 12(7):544-555. PubMed ID: 38643780
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003.
Kobaly K; Schluchter M; Minich N; Friedman H; Taylor HG; Wilson-Costello D; Hack M
Pediatrics; 2008 Jan; 121(1):73-81. PubMed ID: 18166559
[TBL] [Abstract][Full Text] [Related]
9. Physiology and Predictors of Impaired Gas Exchange in Infants with Bronchopulmonary Dysplasia.
Svedenkrans J; Stoecklin B; Jones JG; Doherty DA; Pillow JJ
Am J Respir Crit Care Med; 2019 Aug; 200(4):471-480. PubMed ID: 30789787
[No Abstract] [Full Text] [Related]
10. Immediate postnatal prediction of death or bronchopulmonary dysplasia among very preterm and very low birth weight infants based on gradient boosting decision trees algorithm: A nationwide database study in Japan.
Yoneda K; Seki T; Kawazoe Y; Ohe K; Takahashi N;
PLoS One; 2024; 19(3):e0300817. PubMed ID: 38536822
[TBL] [Abstract][Full Text] [Related]
11. Bronchopulmonary dysplasia in very low birth weight infants.
Demirel N; Bas AY; Zenciroglu A
Indian J Pediatr; 2009 Jul; 76(7):695-8. PubMed ID: 19381510
[TBL] [Abstract][Full Text] [Related]
12. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates.
Isayama T; Lee SK; Yang J; Lee D; Daspal S; Dunn M; Shah PS;
JAMA Pediatr; 2017 Mar; 171(3):271-279. PubMed ID: 28114678
[TBL] [Abstract][Full Text] [Related]
14. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
[TBL] [Abstract][Full Text] [Related]
15. An Early Prediction Model for Estimating Bronchopulmonary Dysplasia in Preterm Infants.
Kostekci YE; Bakırarar B; Okulu E; Erdeve O; Atasay B; Arsan S
Neonatology; 2023; 120(6):709-717. PubMed ID: 37725910
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
[No Abstract] [Full Text] [Related]
17. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
[TBL] [Abstract][Full Text] [Related]
18. Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors.
Kiciński P; Kęsiak M; Nowiczewski M; Gulczyńska E
Pol Merkur Lekarski; 2017 Feb; 42(248):71-75. PubMed ID: 28258680
[TBL] [Abstract][Full Text] [Related]
19. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
[TBL] [Abstract][Full Text] [Related]
20. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
Chen X; Li H; Qiu X; Yang C; Walther FJ
BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
